Vibativ
Active Ingredient(s): TelavancinFDA Approved: * September 11, 2009
Pharm Company: * THERAVANCE INC
Category: Antibiotics
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Vibativ Overview
Telavancin (trade name Vibativ) is a bactericidal lipoglycopeptide for use in MRSA or other Gram-positive infections. Telavancin is a semi-synthetic derivative of vancomycin.[1][2] The FDA approved the drug in September 2009 for complicated skin and skin structure infections (cSSSI),[3] and in June 2013 for hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus.[4] Contents 1 History 2 M...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Telavancin
Recent Vibativ Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Telavancin
- Injection: 250mg, 750mg
- Powder: 250mg/vial, 750mg/vial
NDC Database Records for Vibativ: (6 results)
Sorted by National Drug Code- 0469-3525 Vibativ 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
- 0469-3575 Vibativ 750 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
- 52118-001 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
- 52118-002 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
- 62847-001 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.
- 62847-002 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.